Pioneering innovation, sustainable strategy.

As one of India's richest men and an icon in the global pharmaceutical industry, billionaire Dilip Shanghvi stands out not only for his outstanding business career but also for his strategic vision of sustainable development and international cooperation.

When a group of 4,500 Indian tourists arrived in Vietnam, many eyes turned to the man behind this "invasion": billionaire Dilip Shanghvi, founder and head of the pharmaceutical conglomerate Sun Pharmaceutical Industries Limited (Sun Pharma).

Billionaire Dilip Shanghvi is one of the richest people in India. (Source: GQ India)

From 10,000 Rupees to the pinnacle of a career.

The 67-year-old Indian billionaire was born and raised in a small pharmaceutical family in Amreli, Gujarat. From a young age, Shanghvi's life revolved around his father's pharmacy in the bustling and crowded Dawa Bazar market. After completing his studies at Calcutta University, he took over his father's business and quickly realized his ambitions were much greater. The boy who once fascinated reading drug labels decided to manufacture his own medicines and made a brilliant mark in India's pharmaceutical market, which is dominated by giants.

In 1983, Shanghvi founded Sun Pharma with a 10,000 Rupee loan from his father. In the early years of his career, the Indian pharmaceutical market was largely dominated by established names, and overcoming this required not only innovation but also perseverance.

Therefore, young Shanghvi threw himself into the relentless work, dedicating countless hours to ensuring the highest standards of production and adherence to ethical regulations. Starting with a small manufacturing facility, the entrepreneur gradually expanded his business, transforming it into India's largest pharmaceutical conglomerate and one of the world's largest generic drug companies.

In March 2015, the founder and CEO of Sun Pharma became the richest person in the country, surpassing billionaire Mukesh Ambani, chairman of Reliance Industries. To this day, Dilip Shanghvi remains among the top 10 wealthiest people in the world's most populous nation.

Sun Pharma Group is the largest pharmaceutical company in India. (Source: GQ India)

Global vision and sustainable business philosophy

In the early days of entering the pharmaceutical market, one of the key challenges was gaining the trust of both doctors and patients. Shanghvi understood that building a reputable brand required not only effective products but also consistent quality and ethical business practices. He invested heavily in research and development, creating low-cost yet high-quality generic drugs that helped millions access healthcare .

Dilip Shanghvi is not only a brilliant businessman but also a pioneer in taking Sun Pharma global. Under the leadership of billionaire Dilip Shanghvi, Sun Pharma is determined to “grow faster than the pharmaceutical industry,” aiming to become the world's leading pharmaceutical company and committed to providing high-quality, accessible healthcare solutions for people worldwide. The company focuses on developing breakthrough drugs, including generics and new therapies.

Sun Pharma's mission is to improve the health and quality of life of people around the world by providing innovative, safe, and economically valuable healthcare products. The company is committed to investing heavily in research and development to create new specialized drugs for cancer, neurological diseases, and more, while expanding its product portfolio to meet the growing needs of patients and healthcare systems globally. Mr. Shanghvi believes that innovation is key to maintaining and strengthening the company's position in this highly competitive industry.

Mr. Dilip Shanghvi emphasized that Sun Pharma is maintaining a growth rate faster than the global pharmaceutical industry average. This is achieved through expanding production scale, diversifying its product portfolio, and expanding into international markets. The company is not only focusing on major markets such as the US and Europe, but is also expanding into emerging markets with high growth potential.

According to a Forbes India report published on August 19th, Dilip Shanghvi is currently ranked 5th on the list of India's richest people with an estimated net worth of $28.8 billion.
With this fortune, he ranks 61st on the list of the world's richest people.

A key part of Sun Pharma's growth strategy is the acquisition of promising companies and products. The company has undertaken numerous M&A deals to expand its product portfolio, penetrate new markets, and enhance its production and research capabilities. These acquisitions have not only helped Sun Pharma rapidly expand its scale but also added to its research and development capacity for new therapies.

Mr. Shanghvi emphasized that Sun Pharma's goal is not only profit but also sustainable development and social responsibility. The pharmaceutical giant is committed to conducting environmentally responsible business practices while promoting community programs to improve the health and lives of people in the areas where it operates.

The company places particular emphasis on compliance with legal regulations and business ethics in all its operations. Sun Pharma establishes rigorous quality control processes to ensure that all products meet the highest standards of safety and efficacy.

Dilip Shanghvi believes that innovation is key to maintaining and strengthening the company's position in the pharmaceutical industry. (Source: khojoindia)

Continuously expanding the market.

The event hosting 4,500 Indian tourists in Vietnam, organized by billionaire Dilip Shanghvi, was not just a typical trip, but also part of Sun Pharma's strategy to expand and strengthen its international influence.

This trip also provided an opportunity for the corporation to gain a deeper understanding of the Vietnamese market, expand partnerships, and promote innovative ideas in the healthcare sector. For Mr. Shanghvi, this was not only about exploring a new market but also about building strong and lasting relationships with local partners, opening up opportunities for sustainable cooperation and development.

Billionaire Dilip Shanghvi has always believed in building relationships based on trust and sincerity. He understands that in the highly competitive business world, genuine human relationships and cooperation are key to sustainable success. Through this tourism event, he has created a cultural and economic bridge, not only connecting Indian and Vietnamese business partners but also expanding friendly relations between the two countries. The visit is expected to provide unique experiences for tourists, while promoting the image of Vietnam in general and its scenic attractions to the international community.

Bringing 4,500 employees to Vietnam marks a significant step in Sun Pharma's international cooperation strategy. This is not only an opportunity to expand markets and find new partners, but also demonstrates Mr. Shanghvi's commitment to building a global business community based on sustainable development and social responsibility.

Hanoi welcomed the first group of 4,500 Indian tourists to Vietnam on August 27th.

The story of billionaire Dilip Shanghvi is a testament to the perfect combination of business vision and social mission. He is not only a successful businessman but also a visionary leader, focused on creating real value for the community and society.

Source: https://baoquocte.vn/ty-phu-dilip-shanghvi-tien-phong-trong-doi-moi-ben-vung-trong-chien-luoc-284535.html